GL67
CAS: 179075-30-0
Ref. 3D-EHA07530
1mg | A consultar | ||
2mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar |
Informação sobre produto
GL67 is an experimental cancer gene therapy agent with minimal toxicity and a very low potential for adverse effects. It consists of magnetic particles that are injected into the bloodstream and taken up by cells in the tumor, where they can be activated using light to emit heat. This heat damages the tumor cells, leading to cell death. GL67 is designed to produce interleukin-2 (IL-2) in vivo, which stimulates the immune system to attack cancer cells. In animal studies, GL67 has been shown to inhibit transcription-polymerase chain reaction (PCR) activity and reduce acid complex production in chronic pulmonary tumors. GL67 has also been shown to inhibit messenger RNA (mRNA) expression of IL-8, a molecule involved in inflammation, while increasing mRNA expression of IL-10, a molecule involved in anti-inflammatory activities.
Propriedades químicas
Consulta técnica sobre: 3D-EHA07530 GL67
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.